Funding Opportunities for Adverse Drug Reaction Research through the European Commission’s 7th Framework Programme

Published 26th July 2010

For further information see:
- Announcement of European Medicines Agency priorities for adverse drug reaction research – 5th Call FP7

Are you interested in any of the research topics and looking for partners? Facilitating the establishment of Consortia...

In an effort to stimulate collaboration and thus facilitate the establishment of consortia, the ENCePP Secretariat has created a new section in the ENCePP partners’ forum entitled “FP7 5th Call”, with subsections for each topic. We hope this will give ENCePP partners the opportunity to express their interest in participating (or even leading a project consortium!) in each individual topic.

Workshop for SMEs

 This message is targeted at service providers with expertise in the field of pharmacovigilance, pharmacoepidemiology and health outcome research.

The European Medicines Agency and the European Commission DG Research are considering organising a joint workshop for SMEs on 13 September 2010 at the EMA in London to raise awareness of the potential funding opportunities through the 7th Framework Programme for health research in 2011. The aim is to increase awareness of the Framework Programme, provide guidance on the application procedures and ultimately encourage applications from SMEs.

For further information and to register your interest, please go to the European Medicines Agency website